Orphazyme was founded in 2009 with the objective to develop new therapies for patients suffering from protein-misfolding diseases with no or limited treatment options available. The company was based on a scientific discovery on the function of Heat-Shock Proteins (HSPs) by Thomas Kirkegaard Jensen and Professor Marja Jäättelä that was published in the scientific journal Nature. Since inception, Orphazyme has translated the...
Orphazyme was founded in 2009 with the objective to develop new therapies for patients suffering from protein-misfolding diseases with no or limited treatment options available. The company was based on a scientific discovery on the function of Heat-Shock Proteins (HSPs) by Thomas Kirkegaard Jensen and Professor Marja Jäättelä that was published in the scientific journal Nature. Since inception, Orphazyme has translated the scientific discovery into a late-stage clinical development program.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.